These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30682491)

  • 1. The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir.
    Kubbinga M; Augustijns P; García MA; Heinen C; Wortelboer HM; Verwei M; Langguth P
    Eur J Pharm Biopharm; 2019 Mar; 136():147-155. PubMed ID: 30682491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
    Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of permeability enhancers on paracellular permeability of acyclovir.
    Ates M; Kaynak MS; Sahin S
    J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
    Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel food drug interaction mechanism involving acyclovir, chitosan and endogenous mucus.
    García MA; Hensler G; Al-Gousous J; Pielenhofer J; Wagner M; Lennernäs H; Langguth P
    Drug Metab Pharmacokinet; 2023 Apr; 49():100491. PubMed ID: 36805824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats.
    Masuda A; Goto Y; Kurosaki Y; Aiba T
    J Pharm Sci; 2012 Jul; 101(7):2449-56. PubMed ID: 22535511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
    Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
    Drug Dev Ind Pharm; 2008 Mar; 34(3):279-88. PubMed ID: 18363143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated Lipid Polymeric Nanoparticle-Encapsulated Acyclovir for In Vitro Controlled Release and Ex Vivo Gut Sac Permeation.
    Mahmood S; Kiong KC; Tham CS; Chien TC; Hilles AR; Venugopal JR
    AAPS PharmSciTech; 2020 Oct; 21(7):285. PubMed ID: 33057878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ball-milled solid dispersions of BCS Class IV drugs: Impact on the dissolution rate and intestinal permeability of acyclovir.
    Nart V; França MT; Anzilaggo D; Riekes MK; Kratz JM; de Campos CE; Simões CM; Stulzer HK
    Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():229-38. PubMed ID: 26042711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interesting Case of Acyclovir Delivered Using Chitosan in Humans: Is it a Drug Issue or Formulation Issue?
    Srinivas NR
    Pharm Res; 2016 Mar; 33(3):543-7. PubMed ID: 26474764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
    Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
    Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased acyclovir oral bioavailability via a bile acid conjugate.
    Tolle-Sander S; Lentz KA; Maeda DY; Coop A; Polli JE
    Mol Pharm; 2004 Jan; 1(1):40-8. PubMed ID: 15832499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF; Hombach J; Bernkop-Schnürch A
    Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
    Thanou M; Verhoef JC; Marbach P; Junginger HE
    J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
    Schipper NG; Vârum KM; Stenberg P; Ocklind G; Lennernäs H; Artursson P
    Eur J Pharm Sci; 1999 Aug; 8(4):335-43. PubMed ID: 10425384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
    Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
    Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
    Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
    J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Ussing Chamber and Caco-2 Model in Evaluation of Intestinal Absorption Mechanism of Compounds from Different BCS Classifications.
    Tian D; Yang Y; Zhang H; Du H; Zhou H; Wang T
    Drug Metab Bioanal Lett; 2023; 16(2):105-112. PubMed ID: 37711012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs.
    Dahlgren D; Roos C; Johansson P; Tannergren C; Lundqvist A; Langguth P; Sjöblom M; Sjögren E; Lennernäs H
    Int J Pharm; 2018 Aug; 547(1-2):158-168. PubMed ID: 29758344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Chitosan on the Oral Bioavailability of Acyclovir--a Comparative Bioavailability Study in Humans.
    Kubbinga M; Nguyen MA; Staubach P; Teerenstra S; Langguth P
    Pharm Res; 2015 Jul; 32(7):2241-9. PubMed ID: 25609011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.